Tachycardia-induced cardiomyopathy, without the tachycardia: Yet another reason to ablate atrial fibrillation

Journal of Cardiovascular Electrophysiology

Volumn 18, Issue 1, 2007, Pages 15-17

  Asirvatham, Samuel J ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOMYOPATHY; CATHETER ABLATION; HEART ATRIUM FIBRILLATION; HEART ELECTROPHYSIOLOGY; HEART FAILURE; HEART VENTRICLE EJECTION; HEART VENTRICLE FUNCTION; HUMAN; NOTE; PRIORITY JOURNAL; SINUS RHYTHM; STROKE; SUDDEN DEATH; TACHYCARDIA; TACHYCARDIA INDUCED CARDIOMYOPATHY;

ATRIAL FIBRILLATION; CARDIOMYOPATHIES; CATHETER ABLATION; HUMANS; PROGNOSIS;

EID: 33845681202     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/j.1540-8167.2006.00694.x     Document Type: Note

References (23)

1. The Planning and Steering Committees of the AFFIRM study for the NHLBI AFFIRM investigators: Atrial fibrillation follow-up investigation of rhythm management - The AFFIRM study design. Am J Cardiol 1997;79:1198-1202.
2. Feld G: Atrial fibrillation. Is there a safe and highly effective pharmacological treatment? Circulation 1990;82:2248-2250.
3. Nattel S: Rhythm versus rate control for atrial fibrillation management: What recent randomized clinical trials allow us to affirm. CMAJ 2003;168:572-573.
4. Packer D, Asirvatham S, Munger T: Progress in nonpharmacologic therapy of atrial fibrillation. J Cardiovasc Electrophysiol 2003;14:S296-S309.
5. Pappone C, Oral H, Santinelli V: Atrio-esophageal fistula as a complication of percutaneous transcatheter ablation of atrial fibrillation. Circulation 2004;16:2724-2726.
6. Dries D, Exner D, Gersh B: Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: A retrospective analysis of the SOLVD trials. Studies of left ventricular dysfunction. J Am Coll Cardiol 1998;32:695-703.
7. Haissagurre M, Shah D, Jais P, Hocini M, Yamane T, Deisenhofer I, Garrigue S, Clementy J: Mapping-guided ablation of pulmonary veins to cure atrial fibrillation. Am J Cardiol 2000;86(Suppl):K9-K19.
8. Pappone C, Rosanio S, Augello G, Gallus G, Vicedomini G, Mazzone P, Gulletta S, Gugliotta F, Pappone C, Santinelli V, Tortoriello V, Sala S, Zangrillo A, Crescenzi G, Benussi S, Alfieri O: Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation: Outcomes from a controlled nonrandomized long-term study. J Am Coll Cardiol 2003;42:185-197.
9. Wolf P, Abbott R, Kannel W: Atrial fibrillation: A major contributor to stroke in the elderly. Framingham study. Arch Intern Med 1987;147:1561-1564.
10. Gentlesk P, Sauer W, Gerstenfeld E, Lin D, Dixit S, Zado E, Callas D, Marchlinski F: Reversal of left ventricular dysfunction following ablation of atrial fibrillation. J Cardiovasc Electrophysiol 2007;18:9-14.
11. Grogan M, Smith H, Gersh B, Wood D: Left ventricular dysfunction due to atrial fibrillation in patients initially believed to have idiopathic dilated cardiomyopathy. Am J Cardiol 1992;69:1570-1573.
12. Redfield M, Kay G, Jenkins L, Mianulli M, Jensen D, Ellenbogen K: Tachycardia-related cardiomyopathy: A common cause of ventricular dysfunction in patients with atrial fibrillation referred for atrioventricular ablation. Mayo Clinic Proc 2000;75:790-795.
13. Brookes C, White P, Staples M: Myocardial contractility is nt constant during spontaneous atrial fibrillation in patients. Circulation 1998;98:1762-1768.
14. Patton J, Allen J, Pantridge J: The effects of shock energy, propranolol, and verapamil on cardiac damage caused by transthoracic countershock. Circulation 1984;69:357-368.
15. Rawles J: What is meant by a "controlled" ventricular rate in atrial fibrillation? Br Heart J 1990;63:157-161.
16. Senatore G, Stabile G, Bertaglia E: Role of transtelephonic electrocardiographic monitoring in detecting short-term arrhythmia recurrences after radiofrequency ablation in patients with atrial fibrillation. J Am Coll Cardiol 2005;45:873-876.
17. Hsu L, Jais P, Sanders P: Catheter ablation for atrial fibrillation in congestive heart failure. N Engl J Med 2004;351:2373-2383.
18. Clark D, Plumb V, Epstein A: Hemodynamic effects of an irregular sequence of ventricular cycle lengths during atrial fibrillation. J Am Coll Cardiol 1997;30:1039-1045.
19. Naito M, David D, Michelson E: The hemodynamic consequences of cardiac arrhythmias: Evaluation of the relative roles of abnormal atrioventricular sequencing, irregularity of ventricular rhythm and atrial fibrillation in a canine model. Am Heart J 1983;106:284-291.
20. Pappone C, Santinelli V, Manguso F: Pulmonary vein denervation enhances long-term benefit after circumferential ablation for paroxysmal atrial fibrillation. Circulation 2004;109:327-334.
21. Karch M, Zrenner B, Deisenhofer I: Freedom from atrial tachyarrhythmias after catheter ablation of atrial fibrillation: A randomized comparison between 2 current ablation strategies. Circulation 2005;111:2875-2880.
22. Donal E, Grimm R, Yamada H, Kim Y, Marrouche N, Natale A, Thomas J: Usefulness of Doppler assessment of pulmonary vein and left atrial appendage flow following pulmonary vein isolation of chronic atrial fibrillation in predicting recovery of left atrial function. Am J Cardiol 2005;95:941-947.
23. Yamanaka K, Fujita M, Doi K, Tsuneyoshi H, Yamazato A, Ueno K, Zen E, Komeda M: Multislice computed tomography accurately quantifies left atrial size and function after the MAZE procedure. Circulation 2006;114(Suppl I):I-5-I-9.